Skip to main content Skip to main navigation menu Skip to site footer
PAGEPress
  • Bluesky
  • X
  • LinkedIn
Confinia Cephalalgica
  • Search
  • Contacts
  • News
  • Register
  • Login
  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current
  • Archives
  • Copyright
  • Search
  • Contacts
  • News
  • Register
  • Login
  1. Home /
  2. Search

Search

Advanced filters Clear filters
Published After
Published Before

Search Results

8 results for “F. de Santis”

  • OC18 | LONG-TERM EFFECTIVENESS, SAFETY AND TOLERABILITY OF ATOGEPANT IN THE PREVENTION OF MIGRAINE: A MULTICENTRIC, PROSPECTIVE OBSERVATIONAL, REAL WORLD STUDY (THE 48-WEEK STAR STUDY)

    F. Vernieri1|2, L. Francesco Iannone3, M. Marcosano1|2, L. Fofi1, F. Lo Castro4, G. Sebastianelli5, F. De Santis6, M. Corrado7, R. Ornello6, L. Grazzi8, D. Antonio Montisano8, F. De Cesaris9, A. Munafò9, G. Avino10, M. Trimboli11, M. Albanese12, A. Russo13, M. Silvestro13, G. Dalla Volta14, M. Romozzi15, P. Calabresi15, A. Boccalini4, P. Merlo16, M. Pia Prudenzano17, M. Rosaria Valente18, I. Rainero19, G. Giuliani20, M. Altieri20, A. Doretti21, G. Vaghi7|22, F. Pistoia6, D. Ferrandi23, S. Battistini24, G. Coppola5, S. Guerzoni4, S. Sacco6|25, C. Tassorelli7|22, C. Altamura1|2 | 1Headache and Neurosonology Unit, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy; 2Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Italy; 3Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy; 4Digital and Predictive Medicine, Pharmacology and Clinical Metabolic Toxicology-Headache Center and Drug Abuse-Laboratory of Clinical Pharmacology and Pharmacogenomics, AOU Policlinico Di Modena, Italy; 5Sapienza University of Rome, Department of Medico-Surgical Sciences and Biotechnologies, Polo Pontino, Latina, Italy; 6Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, Italy; 7Headache Science and Neurorehabilitation Centre, IRCCS Mondino Foundation, Pavia, Italy; 8Headache Center IRCCS Fondazione Istituto Neurologico "Carlo Besta", Italy; 9Headache center and clinical pharmacology, AOU Careggi, Firenze, Italy; 10Neurology Unit, Ospedale Santo Stefano, USL Toscana Centro, Prato, Italy; 11Azienda Ospedaliera-universitaria "Renato Dulbecco", Catanzaro, Italy; 12Department of Systems Medicine, University of Rome Tor Vergata, Italy; 13Headache Center, Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, Second University of Naples, Italy; 14U.O Neurologia, Istituto Clinico Città di Brescia, Gruppo San Donato, Italy; 15Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy; 16UO di Neurologia, Humanitas Gavazzeni, Bergamo, Italy; 17Clinica Neurologica "L. Amaducci", Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, Italy; 18Clinica Neurologica ASUFC, Dipartimento di Medicina DMED Università di Udine, Italy; 19Headache Center, Department of Neuroscience, University of Torino, Italy; 20Department of Human Neuroscience, Sapienza University of Rome, Italy; 21IRCCS Istituto Auxologico Italiano, Milano, Italy; 22Department of Brain and Behavioural Sciences, University of Pavia, Italy; 23SC Neurologia, Azienda Ospedaliero Universitaria Santi Antonio e Biagio, Alessandria, Italy; 24Department of Medical, Surgical and Neurological Sciences, University of Siena, Italy; 25Neurology and Stroke Unit, ASL 1 Abruzzo, Avezzano-Sulmona-L’Aquila, Italy

    03-11-2026

    DOI https://doi.org/10.4081/cc.2026.15956

    • 0 abstract views
    • 0 PDF
  • P089 | PRELIMINARY VALIDATION OF THE ITALIAN VERSION OF THE UTAH PHOTOPHOBIA SYMPTOM IMPACT SCALE (UPSIS-2) IN PATIENTS WITH MIGRAINE

    A.M. Chiarandon1, E.M. Piella1, V. Batti1, G. Sebastianelli2, F. Ferrandes1, M. Corrado3, M. Romozzi4, F. De Santis5, C. Fasano6, F. Lazzerini7, L. F. Iannone8, A. Munafò9, R. Ornello10, E. Rubino1|11, I. Rainero1|11 | 1Department of Neuroscience “Rita Levi Montalcini”, University of Turin, Italy; 2Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Polo Pontino, Latina, Italy; 3Department of Brain and Behavioral Sciences, University of Pavia, Italy; 4Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome; Università Cattolica del Sacro Cuore, Rome, Italy; 5Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, Italy; 6Headache and Cerebrovascular Diseases Center, Neurology Unit 2, Careggi University Hospital, Florence, Italy; 7Department of Humanities, University of Turin, Italy; 8Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy; 9Headache center and Clinical pharmacology unit, AOU Careggi, Florence, Italy; 10Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Italy; 11Headache Center, Department of Neuroscience and Mental Health, City of Health and Science of Turin, Italy, on behalf of SISC Junior Group

    03-11-2026

    DOI https://doi.org/10.4081/cc.2026.16045

    • 0 abstract views
    • 0 PDF
  • P007 | PRIMARY HEADACHES IN ITALIAN CHILDREN AND ADOLESCENTS: EPIDEMIOLOGY AND CLINICAL PROFILE FROM THE REPICEF STUDY

    A. Onofri, C. Rosignoli, F. De Santis, R. Ornello, S. Sacco | Dipartimento di Scienze Cliniche Applicate e Biotecnologiche, Università degli Studi dell’Aquila, Italy

    03-11-2026

    DOI https://doi.org/10.4081/cc.2026.15963

    • 0 abstract views
    • 0 PDF
  • P094 | SLEEP MACROSTRUCTURE CHANGES ACROSS THE MIGRAINE CYCLE: PRELIMINARY EVIDENCE FROM PROLONGED HOME POLYSOMNOGRAPHIC MONITORING

    E. Piizzi, U. Coppola, A. Cipriano, F. Gabriele, F. De Santis, C. Tiseo, R. Ornello, S. Sacco | Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Italy

    03-11-2026

    DOI https://doi.org/10.4081/cc.2026.16050

    • 0 abstract views
    • 0 PDF
  • P093 | GAINER-AI: PREDICTING ACUTE RIMEGEPANT RESPONSE IN MIGRAINE USING MACHINE LEARNING IN A MULTICENTER REAL-WORLD COHORT

    M. Romozzi1|2, A. Lokhawandala3, G. Vaghi4|5, G. Sebastianelli6, R. Ornello7, F. Casillo6, A. Russo8, M. Silvestro8, F. Pistoia9, G. Saporito9, G. Dalla Volta10, M. Bolchini10, A. Burgalassi11, G. Vigani11, D. Antonio Montisano12, L. Grazzi12, M. Pia Prudenzano13, D. Mascarella14, E. Mampreso15, G. Avino16, M. Valente17, G. Carlucci18, S. Guerzoni19, S. Battistini20, A. Granato21, E. Maria Piella22, I. Rainero22, M. Albanese23, M. Trimboli24, A. Doretti25, F. De Santis7, S. Sacco7, C. Tassorelli4|5, S. Di Tella26, C. Vollono1|2, P. Calabresi1|2, R. De Icco4|5, L. Francesco Iannone27 | 1Dipartimento Universitario di Neuroscienze, Università Cattolica del Sacro Cuore, Rome, Italy; 2Neurologia, Dipartimento di neuroscienze, Organi di Senso e Torace, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; 3Drexel University, Philadelphia, USA; 4Department of Brain and Behavioral Sciences, University of Pavia, Italy; 5Headache Science and Neurorehabilitation Unit, IRCCS Mondino Foundation, Pavia, Italy; 6Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome Polo Pontino, Latina, Italy; 7Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, Italy; 8Headache Centre, Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy; 9Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Italy; 10Headache Center of Clinical Neurology of Istituto Clinico Città Di Brescia, Italy; 11Department of Health Sciences, University of Florence, Italy; 12Neuroalgology Unit and Headache Center, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy; 13Headache Center, Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Italy; 14IRCCS Istituto Di Scienze Neurologiche Di Bologna, Programma Cefalee e Algie Facciali, Italy; 15Headache Centre, Neurology - Euganea, Health Unit, Padua, Italy; 16Neurology Unit, Ospedale Santo Stefano, USL Toscana Centro, Prato, Italy; 17Clinical Neurology, Azienda Sanitaria Universitaria Friuli Centrale, Presidio Ospedaliero Santa Maria Della Misericordia, Udine, Italy; 18NEUROFARBA Department, University of Florence - AOU Careggi, Italy; 19Digital and Predictive Medicine, Pharmacology, Clinical Metabolic Toxicology-Headache Center and Drug Abuse, Laboratory of Clinical Pharmacology and Pharmacogenomics, AOU Policlinico, Modena, Italy; 20Department of Medical, Surgical and Neurological Sciences, University of Siena, Italy; 21Headache Centre, Clinical Unit of Neurology, School of Neurology, Department of Medicine, Surgery and Health Sciences, University Hospital and Health Services of Trieste, ASUGI, University of Trieste, Italy; 22Department of Neurosciences “Rita Levi Montalcini”, University of Turin, Italy; 23Unit of Neurology, Department of Systems Medicine, Tor Vergata University, Rome, Italy; Unit of Neurology - IRCCS Neuromed, Pozzilli (IS), Italy; 24Headache Centre, Neurology Unit, AOU Renato Dulbecco, Catanzaro, Italy; 25Department of Neurology- Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy; 26Dipartimento di Psicologia, Università Cattolica del Sacro Cuore, Milan, Italy; 27Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy

    03-11-2026

    DOI https://doi.org/10.4081/cc.2026.16049

    • 0 abstract views
    • 0 PDF
  • OC05 | MIGRAINE MONITORING AND ATTACK PREDICTION IN THE PREICTAL PHASE USING MACHINE LEARNING APPROACHES COMBINING E-DIARIES AND BIOLOGICAL VARIABLES COLLECTED THROUGH WEARABLE SENSORS: THE MIGRAMETER STUDY

    F. De Santis1, R. Ornello1, R. Guido2, M. Fiaz2, C. Rosignoli1, A. Onofri1, F. Gabriele1, M. Junaid Jawaid1, G. Scatena3, D. Conforti2, S. Sacco1 | 1Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, Italy; 2Dipartimento di Ingegneria Meccanica, Energetica e Gestionale - DIMEG, University of Calabria, Italy; 3Mith S.r.l., Capistrello (AQ), Italy

    03-11-2026

    DOI https://doi.org/10.4081/cc.2026.15943

    • 0 abstract views
    • 0 PDF
  • P018 | LOOKING AT ADHERENCE TO TREATMENTS TARGETING THE CALCITONIN GENE-RELATED PEPTIDE PATHWAY FROM THE LENS OF PHARMACOUTILIZATION: REAL-WORLD DATA

    A. Cipriano, E. Sciarretta, F. Gabriele, F. de Santis, A. Onofri, E. Piizzi, U. Coppola, C. Tiseo, R. Ornello, S. Sacco | Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Italy

    03-11-2026

    DOI https://doi.org/10.4081/cc.2026.15974

    • 0 abstract views
    • 0 PDF
  • OC12 | HEADACHE-ATTRIBUTED BURDEN IN ITALIAN CHILDREN AND ADOLESCENTS: FINDINGS FROM THE REPICEF SCHOOL-BASED STUDY

    A. Onofri, C. Rosignoli, F. De Santis, R. Ornello, S. Sacco | Dipartimento di Scienze Cliniche Applicate e Biotecnologiche, Università degli Studi dell’Aquila, Italy

    03-11-2026

    DOI https://doi.org/10.4081/cc.2026.15950

    • 0 abstract views
    • 0 PDF
1 - 8 of 8 items

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a scientific paper
  • How to write a Review article

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to review

Categories

    • Contents

indexing

INDEXING
  • Scopus
  • OpenAlex
  • Analytics

Keywords

Confinia Cephalalgica

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS. eISSN 3035-0670 (Website continuously updated).

pISSN 1122-0279
eISSN 3035-0670

The journal

  • About the Journal
  • Editorial board
  • Archives
  • Announcements
  • Contact

For authors

  • Submissions
  • Guidelines for authors
  • Privacy Statement
PAGEPress

© PAGEPress 2008–2026. PAGEPress® is a registered trademark property of PAGEPress srl, Italy. VAT IT02125780185. This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.